2m 2m 2m 2m 2m 2m 2m
Ascnd Wll Hldg-A (AAWH)
OTC
$0.38-$0.007 (-1.82%)
Price as of Aug 03, 2026- $78.2MMarket Cap
- -12.09%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Ascnd Wll Hldg-A (AAWH)
$0.38-$0.007 (-1.82%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 500.6M -10.87% | 561.6M +8.29% | 518.6M +27.75% | 405.9M +22.13% | |
Cost of Revenue | 330.9M -12.32% | 377.4M +3.83% | 363.5M +33.94% | 271.4M +38.16% | |
Gross Profit | 169.7M -7.89% | 184.2M +18.75% | 155.1M +15.28% | 134.6M -1.04% | |
Sales and Marketing Expense | 4.1M -13.16% | 4.7M +7.01% | 4.4M +27.14% | 3.4M +16.07% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 73.5M +11.14% | 66.2M +12.16% | 59.0M +58.96% | 37.1M +67.00% | |
Total Operating Expenses | 186.7M +4.02% | 179.5M +13.06% | 158.7M +11.72% | 142.1M -7.24% | |
Operating Profit | -17.0M -459.36% | 4.7M +230.81% | -3.6M -51.91% | -7.5M -56.25% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -51.3M +13.32% | -45.3M +22.39% | -37.0M +14.02% | -32.4M -49.31% | |
Interest Income and Expense and Net | -51.3M +13.32% | -45.3M +22.39% | -37.0M +14.02% | -32.4M -49.31% | |
Total Nonoperating Income and Expense | -49.8M +11.78% | -44.6M +299.93% | -11.1M -64.83% | -31.7M -50.29% | |
Income before Taxes | -66.8M +67.78% | -39.8M +169.80% | -14.8M -62.35% | -39.2M -51.56% | |
Income Taxes | 51.4M +13.74% | 45.2M +35.03% | 33.5M -19.76% | 41.7M -0.06% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -118.2M +39.06% | -85.0M +76.28% | -48.2M -40.40% | -80.9M -34.04% | |
Net Income from Continuing Operations Applicable to Common | -66.8M +67.78% | -39.8M +169.80% | -14.8M -62.35% | -39.2M -51.56% | |
Basic EPS and Net Income | -0.58 +45.00% | -0.40 +66.67% | -0.24 -45.45% | -0.44 -46.34% | |
Diluted EPS and Net Income | -0.58 +45.00% | -0.40 +66.67% | -0.24 -45.45% | -0.44 -46.34% | |
Basic Weighted Average Shares | 203.5M -4.22% | 212.4M +6.67% | 199.2M +8.60% | 183.4M +22.72% | |
Diluted Weighted Average Shares | 203.5M -4.22% | 212.4M +6.67% | 199.2M +8.60% | 183.4M +22.72% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 85.7M -2.92% | 88.3M +21.72% | 72.5M -2.21% | 74.1M -52.31% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 85.7M -2.92% | 88.3M +21.72% | 72.5M -2.21% | 74.1M -52.31% | |
Total Current Assets | 208.9M -8.91% | 229.4M +0.23% | 228.9M +15.15% | 198.7M -22.97% | |
Accumulated Depreciation | 158.4M +35.45% | 116.9M +45.85% | 80.2M +73.12% | 46.3M +117.08% | |
Property and Plant and Equipment and Net | 382.4M +46.82% | 260.5M -2.84% | 268.1M -4.21% | 279.9M +16.78% | |
Total Long-Term Assets | 15.0M -8.74% | 16.4M -28.77% | 23.1M +19.59% | 19.3M -1.47% | |
Total Assets | 907.9M +0.83% | 900.4M -2.08% | 919.5M +5.43% | 872.2M +20.56% | |
Income Taxes Payable | 22.6M -6.37% | 24.1M -32.48% | 35.7M -47.65% | 68.3M +81.58% | |
Total Short-Term Debt | 10.4M -85.97% | 73.9M +562.73% | 11.1M -1.60% | 11.3M -59.45% | |
Total Current Liabilities | 109.0M -24.58% | 144.5M +55.95% | 92.7M -16.46% | 110.9M -5.49% | |
Total Long-Term Debt | 291.1M +24.12% | 234.5M -21.18% | 297.6M -6.81% | 319.3M +38.32% | |
Total Long-Term Liabilities | 210.5M +32.46% | 158.9M +77.34% | 89.6M +494.29% | 15.1M -96.50% | |
Total Liabilities | 954.5M +15.20% | 828.6M +6.69% | 776.7M +9.58% | 708.7M +29.58% | |
Retained Earnings | -518.5M +29.52% | -400.4M +26.95% | -315.4M +18.05% | -267.1M +43.44% | |
Total Stockholders Equity | -47.4M -166.84% | 71.0M -50.32% | 142.9M -12.57% | 163.4M -7.40% | |
Total Shares Outstanding | 202.2M -1.40% | 205.0M -0.89% | 206.9M +10.00% | 188.1M +9.60% | |
Cash Flow | |||||
Cash from Operating Activities | 38.1M -48.08% | 73.3M -2.71% | 75.3M +296.41% | -38.4M -8.10% | |
Capital Expenditures | 26.0M +15.42% | 22.5M -7.07% | 24.2M -70.30% | 81.6M -7.67% | |
Cash from Investing Activities | -45.7M +22.96% | -37.2M -37.89% | -59.9M -47.58% | -114.3M +0.90% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 5.1M +125.09% | -20.4M +19.13% | -17.1M -123.97% | 71.3M -71.76% | |
Financials Ratio | |||||
Gross Margin | 33.90% +3.34% | 32.80% +9.66% | 29.91% -9.77% | 33.15% N/A | |
Operating Margin | -3.40% -503.14% | 0.84% +220.79% | -0.70% -62.36% | -1.85% N/A | |
Return on Assets | -13.07% +39.95% | -9.34% +73.55% | -5.38% -46.93% | -10.14% N/A | |
Return on Equity | -1,004.27% +1,163.41% | -79.49% +152.48% | -31.48% -33.86% | -47.60% N/A | |
Revenue Growth | -10.86% -231.01% | 8.29% -70.12% | 27.75% +25.44% | 22.13% N/A | |
Current Ratio | 1.92 +20.79% | 1.59 -35.73% | 2.47 +37.84% | 1.79 N/A | |
Cash Ratio | 0.79 +28.73% | 0.61 -21.95% | 0.78 +17.06% | 0.67 N/A | |
Debt-to-Equity Ratio | -6.35 -246.25% | 4.35 +101.10% | 2.16 +6.80% | 2.02 N/A | |
Debt-to-Assets Ratio | 0.33 -3.07% | 0.34 +2.03% | 0.34 -11.45% | 0.38 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow